These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12199921)

  • 1. [New therapeutic targets and strategies in lung cancer].
    Sánchez De Cos Escuín J
    Arch Bronconeumol; 2002 Aug; 38(8):386-91. PubMed ID: 12199921
    [No Abstract]   [Full Text] [Related]  

  • 2. [New biological treatments for lung cancer].
    Zalcman G; Richard N; Bergot E
    Rev Pneumol Clin; 2007 Feb; 63(1):20-8. PubMed ID: 17457280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Farnesyl transferase inhibitors in myeloid malignancies.
    Lancet JE; Karp JE
    Blood Rev; 2003 Sep; 17(3):123-9. PubMed ID: 12818222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical strategy for the development of angiogenesis inhibitors.
    Carter SK
    Oncologist; 2000; 5 Suppl 1():51-4. PubMed ID: 10804092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel molecular targeted therapies for refractory thyroid cancer.
    Perez CA; Santos ES; Arango BA; Raez LE; Cohen EE
    Head Neck; 2012 May; 34(5):736-45. PubMed ID: 21544895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in diagnosis and treatment of lung cancer].
    Fukuoka M
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():15-22. PubMed ID: 11989256
    [No Abstract]   [Full Text] [Related]  

  • 7. [Molecular-targeted therapy].
    Tamura T
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):198-202. PubMed ID: 12610866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EORTC-NCI-AACR--14th Symposium. Molecular targets and cancer therapeutics--part II. 19-22 November 2002, Frankfurt, Germany.
    Patterson C
    IDrugs; 2003 Jan; 6(1):27-9. PubMed ID: 12838969
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticancer therapy with angiogenesis inhibitors.
    Ghilardi C; Bani MR; Giavazzi R
    Tumori; 2001; 87(6):S14-6. PubMed ID: 11989610
    [No Abstract]   [Full Text] [Related]  

  • 10. Outpacing cancer.
    Dorans K
    Nat Med; 2009 Jul; 15(7):718-22. PubMed ID: 19584848
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tumor response to gefitinib (IRESSA) in pulmonary adenocarcinoma: toward a molecular basis for therapeutic targetting].
    Madelaine J; Cadranel J; Zalcman G
    Rev Mal Respir; 2004 Nov; 21(5 Pt 1):881-5. PubMed ID: 15622331
    [No Abstract]   [Full Text] [Related]  

  • 12. Tyrosine kinase signal transduction inhibitors. Clinical trials.
    Scagliotti GV
    Suppl Tumori; 2002; 1(4):S34-6. PubMed ID: 12415814
    [No Abstract]   [Full Text] [Related]  

  • 13. STI571 (glivec-tm): a new paradigm for the development of innovative therapies in onco-hematology?
    Gambacorti C
    Tumori; 2001; 87(6):S10-2. PubMed ID: 11989608
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in the management of colorectal cancer.
    Van Cutsem E; Dicato M; Wils J
    Eur J Cancer; 2001 Dec; 37(18):2302-9. PubMed ID: 11720822
    [No Abstract]   [Full Text] [Related]  

  • 15. The rational basis of using novel targeted biological agents in non-small cell lung cancer.
    Ciardiello F
    Suppl Tumori; 2002; 1(4):S31-3. PubMed ID: 12415813
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer treatment. New drugs, new hope.
    Harv Health Lett; 2001 Jul; 26(9):1-3. PubMed ID: 11511447
    [No Abstract]   [Full Text] [Related]  

  • 17. New drugs in acute myeloid leukemia.
    Grever MR
    Clin Adv Hematol Oncol; 2003 Aug; 1(8):456-9. PubMed ID: 16258431
    [No Abstract]   [Full Text] [Related]  

  • 18. Second/third/fourth line therapy with tyrosine kinase inhibitors in NSCLC.
    Van Zandwijk N; Baas P
    Suppl Tumori; 2002; 1(4):S37-8. PubMed ID: 12415815
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of targeted agents in the treatment of elderly patients with non-small cell lung cancer (NSCLC).
    Owonikoko TK; Ramalingam S
    Curr Treat Options Oncol; 2008 Dec; 9(4-6):313-25. PubMed ID: 18998213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New chemotherapeutic agents: update of major chemoradiation trials in solid tumors.
    Curran WJ
    Oncology; 2002; 63 Suppl 2():29-38. PubMed ID: 12466642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.